Fulcrum Therapeutics

2 followers

‌

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Alex C. Sapir

President, CEO & Board Member

Alex C. Sapir

Collapse

Mel Hayes

Chief Operating Officer

Curtis Oltmans

Chief Legal Officer

Kim Hazen

Chief People Officer

Jeff Jacobs

Chief Scientific Officer And Head Of Technical Operations

Alan Musso

Chief Financial Officer

Iain Fraser

Interim Chief Medical Officer

Mani Sundararajan

SVP, Technical Operations

Bassel Iskandarani

Head Of Drug Product Development

Swathi Srivatsa

Senior Director, New Product Planning & FSHD Brand Lead

Teams

Scientific Research and Development

11 members

Operations and Development

10 members

Board Governance Team

9 members

Clinical Affairs Team

8 members

Leadership Team

4 members

Medical and Clinical Operations

5 members

Similar companies

Springboard Collaborative

144 followers

Stemline Therapeutics

3 followers

Spero Therapeutics

2 followers

Aizon

4 followers

Invivyd

1 follower

Invaio Sciences

1 follower

TopstepTrader

1 follower

Thermo Fisher Scientific

167 followers

Genentech

150 followers

Biogen

115 followers

Regeneron

94 followers

Explore companies